ArticleOncology letters2026

Efficacy and safety of concurrent chemoradiotherapy following neoadjuvant chemoimmunotherapy in patients with stage III NSCLC who experienced neoadjuvant failure: A real-world study.

Ruoxuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.